Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium peroxyborate, commonly known as sodium perborate, is an inorganic oxidizing antiseptic used primarily in oral hygiene. When dissolved in water, it releases hydrogen peroxide, which provides broad-spectrum antimicrobial activity by oxidizing bacterial cell components and disrupting oral bacterial biofilms (dental plaque). It is indicated for the prevention and treatment of gingivitis and the maintenance of general oral health. The compound has been extensively studied by the Academic Centre for Dentistry Amsterdam (ACTA) as part of long-term preventive strategies for oral health. It was historically marketed under the brand name Bocasan by Oral-B Laboratories.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium perborate.